Radiation-induced xerostomia in patients with head and neck cancer: a literature review. (Q36641026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Radiation-induced xerostomia in patients with head and neck cancer: a literature review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Piet Dirix

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Walter Van den Bogaert

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2525-2534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

Chlorhexidine rinse in prevention of dental caries in patients following radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22302

1 reference

7 January 2021

Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Radiotherapy for cancer of the head and neck: altered fractionation regimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Concomitant chemotherapy and radiation therapy certainly improves local control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Toxicity in head and neck cancer: a review of trends and issues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Late effects of radiation therapy in the head and neck region

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The enigmatic mechanism of irradiation-induced damage to the major salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

On the mechanism of salivary gland radiosensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Radiation-induced salivary dysfunction: clinical course and significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Effect of fractionated radiotherapy on salivary gland function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Long-term parotid gland function after radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The relationships between xerostomia and dysphagia after chemoradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Methods for collecting saliva

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

How should we measure and report radiotherapy-induced xerostomia?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Salivary flow and its relation with oral symptoms in terminally ill patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

3D MR sialography protocol for postradiotherapy follow-up of the salivary duct system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Diffusion-weighted imaging of the parotid gland: Influence of the choice of b-values on the apparent diffusion coefficient value

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Quality of life and oral function following radiotherapy for head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Mastication and swallowing in patients with postirradiation xerostomia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Structural mobility in deglutition after single modality treatment of head and neck carcinomas with radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Effects of xerostomia on perception and performance of swallow function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Biology of taste buds and the clinical problem of taste loss

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Preservation of parotid function with uncomplicated conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Xerostomia following radiotherapy of the head and neck affects vocal function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Speech intelligibility and quality of life in head and neck cancer survivors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Caries incidence, mutans streptococci and lactobacilli in irradiated patients during a 12-month preventive programme using chlorhexidine and fluoride

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Caries incidence, salivary flow rate and efficacy of fluoride gel treatment in irradiated patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Oral complications in the head and neck radiation patient. Introduction and scope of the problem

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

A return to "normal eating" after curative treatment for oral cancer. What are the long-term prospects?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Fractionation studies with WR-2721: normal tissues and tumour

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Influence of WR 2721 on radiation response of canine soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Does amifostine have a role in chemoradiation treatment?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Intensity-modulated radiotherapy: is xerostomia still prevalent?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Volume effects and region-dependent radiosensitivity of the parotid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Radioprotective effect of amifostine on parotid gland functioning is region dependent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Submandibular salivary gland transfer prevents radiation-induced xerostomia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Submandibular gland transfer: a new method of preventing radiation-induced xerostomia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Upfront submandibular salivary gland transfer in pharyngeal cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The efficacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The efficacy of chlorhexidine gel in reduction of Streptococcus mutans and Lactobacillus species in patients treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The lacunar sulci: a new test to measure the shrinkage of ocular surface, and its relation with the number of goblet cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22302

7 January 2021

Identifiers

DOI

10.1002/CNCR.22302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078052%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference